These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 183322)

  • 41. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of hyperlipoproteinaemia type II A with a new anion exchange resin secholex.
    Gustafson A; Lanner A
    Eur J Clin Pharmacol; 1974; 7(1):65-9. PubMed ID: 4369397
    [No Abstract]   [Full Text] [Related]  

  • 43. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
    Kaffarnik H; Schneider J; Haase W
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER; Sutherland WH; Temple Wa
    N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 46. Treating lipid disorders.
    Manninen V; Mälkönen M; Tuomilehto J
    Am Heart J; 1979 May; 97(5):674-6. PubMed ID: 219673
    [No Abstract]   [Full Text] [Related]  

  • 47. The treatment of hyperlipidemia.
    Lees RS; Wilson DE
    N Engl J Med; 1971 Jan; 284(4):186-95. PubMed ID: 4923684
    [No Abstract]   [Full Text] [Related]  

  • 48. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
    Schwartzkopff W; Zschiedrich M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():825-9. PubMed ID: 196436
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of combined procetofene--nicotinic acid therapy in treatment of hypertriglyceridaemia.
    Rössner S; Olsson AG
    Atherosclerosis; 1980 Apr; 35(4):413-7. PubMed ID: 7378121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
    Loizzi P; Terlizzi N
    Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of dietary treatment on lipoprotein levels in hyperlipoproteinaemia.
    Vessby B; Lithell H; Gustafsson IB
    Postgrad Med J; 1975; 51(8):suppl 52-9. PubMed ID: 215981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypolipidaemic agents: What are they good for?
    Manninen V; Mälkönen M; Tuomilehto J
    Lancet; 1977 Dec; 2(8051):1281-2. PubMed ID: 73969
    [No Abstract]   [Full Text] [Related]  

  • 54. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
    Huth K; Blumenthal J; Schmahl FW
    Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hyperlipoproteinemia].
    Meinders AE
    Ned Tijdschr Geneeskd; 1979 Mar; 123(15):617-28. PubMed ID: 219378
    [No Abstract]   [Full Text] [Related]  

  • 56. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
    Mann JI; Harding PA; Turner RC; Wilkinson RH
    Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
    Jung W; Kremer GJ; Müller D
    MMW Munch Med Wochenschr; 1975 Oct; 117(44):1783-6. PubMed ID: 171564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
    Krivoruchenko IV; Nikul'cheva NG
    Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypolipidemic drugs and lipoprotein metabolism.
    Levy RI; Langer T
    Adv Exp Med Biol; 1972; 26(0):155-63. PubMed ID: 4370081
    [No Abstract]   [Full Text] [Related]  

  • 60. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
    Neuman J; de Neuman MP; Talmasky S; Pesce R; Valero E; Martiarena JL
    J Cardiovasc Surg (Torino); 1973; Spec No():532-7. PubMed ID: 4377715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.